Target intelligence / Profile preview

Bacterial ribosomal protein 50S subunit (50S subunit)

Target
50S subunit
Molecular classification
Ribosome, Ribosomal subunit, Ribonucleoprotein complex, Other
01

Overview

The **bacterial ribosomal protein 50S subunit** is the larger component of the prokaryotic 70S ribosome and consists mainly of proteins and two ribosomal RNAs (23S and 5S rRNA)[1][4]. It plays a central role in protein synthesis by catalyzing peptide bond formation and providing binding sites for tRNAs during translation. The 50S subunit is a **major target for multiple classes of antibiotics**, including macrolides, lincosamides, streptogramins, and oxazolidinones, which exert their antibacterial effects by inhibiting ribosome assembly, blocking peptidyl transferase activity, or preventing subunit interactions[2][3][8]. Resistance to these antibiotics often arises from enzymatic modification of rRNA or alterations in ribosomal proteins[5]. The essential function of the 50S subunit and its well-characterized structure make it a highly validated and chemically tractable target for antibacterial therapy[1][8].

Other names
Prokaryotic large ribosomal subunit50S ribosomal subunit
02

Mechanism of action

Inhibition of ribosomal assembly (prevents formation of mature 50S subunit); Disruption of protein synthesis (blocks peptidyl transferase reaction, inhibits peptide bond formation); Prevention of 50S-30S subunit interaction; Blocking of elongation/translocation steps in protein synthesis; Inhibiting interaction with elongation factors (EF-G, EF-Tu); rRNA methylation (antibiotic resistance mechanism)

03

Biological functions

Protein synthesisTranslationPeptidyl transferase activity
04

Disease associations

Infection (antibiotic target)Other
05

Safety considerations

Development of antibiotic resistance via rRNA methylation or other ribosomal modificationsBroad-spectrum inhibition may impact commensal bacterial populationsPotential for cross-resistance with drugs targeting similar ribosomal sites
06

Interacting drugs

Erythromycin

18 more in the full profile.

Beyond the preview

Go deeper on Bacterial ribosomal protein 50S subunit (50S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial ribosomal protein 50S subunit (50S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call